Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Similar documents
GLP in the European Union Ecolabel detergents, GLP and accreditation

FoodDrinkEurope Position on GLP studies

Feedback from the Member States questionnaire

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

This document is a preview generated by EVS

Smokefree Policies in Europe: Are we there yet?

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

Official Journal of the European Union

Homeopathy and Anthroposophic Medicine THEIR PLACE IN EUROPEAN HEALTH CARE

COMMISSION OF THE EUROPEAN COMMUNITIES

Archives - Implementation of the GLP Directives in the European states

FORUM FOR AEROSPACE NDT BOARDS

REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU

Amoxicillin 40 mg Clavulanic acid 10 mg. Clavulanic acid 10 mg. Clavulanic acid 10 mg. Clavulanic acid 10 mg

Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)

Where we stand in EFORT

Nutrient profiles for foods bearing claims

This document is a preview generated by EVS

This document is a preview generated by EVS

Engagement in language assessment / Regions of Europe

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

What s s on the Menu in Europe? - overview and challenges in the first pan- European food consumption survey

Animal species. Member State EU/EEA. Route of administration. Strength. Applicant Name INN Pharmaceutical form. Austria 1

The Identification of Food Safety Priorities using the Delphi Technique

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

Safety Requirements for Long Term Operation or Ageing Aspects and for Design, Construction and Operation of New Nuclear Power Plants

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

EUROPEAN AEROSOL PRODUCTION

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

Meeting of the EU GLP Working Group, February GLP requirements in EU legislation and guidance medical devices

Alexandre Feigenbaum, Dimitrios Spyropoulos, Catherine Joly European Food Safety Authority, Parma - INRA Reims

National Food Chain Safety Office. Directorate of Veterinary Medicinal Product 1107 Budapest, Szállás u. 8. Hungary MUTUAL RECOGNITION PROCEDURE

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL ON FOOD AND FOOD INGREDIENTS TREATED WITH IONISING RADIATION FOR THE YEAR 2015

Overview of drug-induced deaths in Europe - What does the data tell us?

Cross Border Genetic Testing for Rare Diseases

COMMISSION RECOMMENDATION. of

Comparability and quality of experimental data under different quality systems. S. Caroli Istituto Superiore di Sanità Rome

Tandvård Medicintekniska produkter för tandvård Dentala implantat. Dentistry Medical devices for dentistry Dental implants

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Meeting report, September 2005

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

European Collaboration on Dementia. Luxembourg, 13 December 2006

Best practices in collecting and processing data in CRC screening and after it

European Partnership for Screening

REPORT OF THE SPECIAL ADVISORY FORUM MEETING ON EU GMO RISK ASSESSMENT

Specific Accreditation Guidance OECD GLP

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Alcohol Prevention Day

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

LEBANON. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018

European Community Pharmacy: a reference in Public Health

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

PLACEMENT AND TREATMENT OF MENTALLY ILL OFFENDERS LEGISLATION AND PRACTICE IN EU-MEMBER STATES

L 322/24 Official Journal of the European Union

PRODUCT INGREDIENT RELATED HEALTH CLAIMS ASSESSMENT for NU SKIN PHARMANEX PRODUCTS in EUROPE

HPAI H5(N8) in Member States in poultry, captive and wild birds

IMPORTANT DISCLAIMER. Note

GERMANY. WCPT COUNTRY PROFILE December 2018

COMMISSION REGULATION (EU)

REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

Foodstuffs - Determination of vitamin D by high performance liquid chromatography - Measurement of cholecalciferol (D3) or ergocalciferol (D2)

Workshop on Accident Analysis and Risk Assessment A JRC Enlargement Workshop

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

The health economic landscape of cancer in Europe

European Status report on Alcohol and Health

2007 Annual Report on Pesticide Residues. according to Article 32 of Regulation (EC) No 396/ Prepared by Pesticides Unit (PRAPeR) of EFSA

'SECTION B EU PARTY. The following abbreviations are used:

This document is a preview generated by EVS


Market surveillance of medical devices

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

DIRECTIVES. (Text with EEA relevance)

This document is a preview generated by EVS

EFSA Statement regarding the EU assessment of glyphosate and the socalled

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL ON FOOD INGREDIENTS TREATED WITH IONISING RADIATION FOR THE YEAR 2012

Recalling Resolution (59) 23 of 16 November 1959, on the extension of the activities of the Council of Europe in the social and cultural fields;

Where do EU Contries set the limit for low risk drinking.

This document is a preview generated by EVS

European status report on alcohol and health Leadership, awareness and commitment

European Parliament Interest Group on CAM Brussels, 16 November 2010

HIV testing in Europe: From policy to effectiveness

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

Transcription:

Good Laboratory Practice EU-Serbia screening meeting Brussels, 19 June 2014

Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role of the European Commission

Purpose of GLP principles Principles of GLP ensure the quality and validity of data generated in non-clinical safety studies for regulatory purposes. GLP is a quality system and a management tool concerned with how safety studies are organised, planned, performed, reported, reviewed and archived, allowing the reconstruction of the study to test data integrity. Comparable quality of test data forms the basis for mutual acceptance of data among countries, which helps avoid duplicative testing, thereby saving time and resources.

Content of GLP principles 1. Test facility organisation and personnel 2. Quality assurance programme 3. Facilities 4. Apparatus, material & reagents 5. Test systems 6. Test & reference items 7. Standard operating procedures 8. Performance of the study 9. Reporting of the study results 10.Storage and retention of records and materials

History of GLP principles Cases of fabrication of data, removal of health effect findings from reports, unexplained changes in the animal data, uncovered by the FDA in the 1970s, led to the first local GLP Regulations OECD Council Act on Mutual Acceptance of Data (MAD) in the Assessment of Chemicals (C(81)30), including the OECD Test Guidelines (Annex I) and the OECD Principles of GLP (Annex II) OECD Council Act on Compliance with Principles of GLP (C(89)87), including guidance for monitoring procedures, test facility inspections and study audits. Implementation in EEC Directives 87/017/EEC and 88/320/EEC, later replaced by 2004/10/EC and 2004/9/EC

Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role of the European Commission

EU legal basis for GLP Directive 2004/10/EC (11 February 2004) on the harmonisation of laws, regulations and administrative provisions relating to the application of the principles of good laboratory practice and the verification of their applications for tests on chemical substances (based on Council Directive 87/18/EEC) Includes the OECD principles of GLP in Annex I Directive 2004/9/EC (11 February 2004) on the inspection and verification of good laboratory practice (GLP) (based on Council Directive 88/320/EEC) Includes the OECD guidance for compliance monitoring procedures, test facility inspections and study audits in Annex I Directives transposed into national legislation

EU legal basis for GLP Directive 2004/10/EC Article 1: "Member States shall take all measures to ensure that laboratories carrying out tests on chemical products, in accordance with Directive 67/548/EEC, comply with the principles of good laboratory practice" [or] "where other Community provisions provide for the application of the principles of GLP" Chemicals (Reg. 1907/2006 & 1272/2008) Human medicinal products (Dir. 2003/63/EC am. 2001/83/EC) Veterinary products (Dir. 2009/9/EC am. 2001/82/EC) Detergents (Reg. 648/2004) Feed additives (Reg. 429/2008) Food additives (Reg. 234/2011) GM food/feed (Reg. 503/2013) Pesticides (Reg. 1107/2009) Biocides (Reg. 528/2012) Cosmetics (Reg. 1223/2009)

EU legal basis for GLP Examples: chemicals & pharmaceuticals Chemicals: REACH Regulation No 1907/2006 Article 13.4: "ecotoxicological and toxicological tests and analyses shall be carried out in compliance with the principles of GLP provided for in Directive 2004/10/EC or other international standards recognised as being equivalent by the Commission or the Agency" Human Medicinal Products: Dir. 2003/63/EC am. 2001/83/EC: Annex: "Non-clinical (pharmaco-toxicological) studies shall be carried out in conformity with the provisions related to Good Laboratory Practice" (Annex) 9

Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role of the European Commission

Role of member states: compliance monitoring Dir. 2004/9/EC, Art. 2(1): "Member States shall verify the compliance with GLP of any testing laboratory within their territory claiming to use GLP in the conduct of tests on chemicals." 748 laboratories in compliance in the EU/EEA in 2012 Country IC Country IC Austria 16 Latvia 1 Belgium 18 Netherlands 30 Czech Rep. 12 Poland 24 Denmark 26 Portugal 4 Finland 12 Slovakia 13 France 110 Slovenia 2 Germany 155 Spain 75 Greece 7 Sweden 15 Hungary 31 UK 113 Ireland 4 Norway 5 Italy 75 Switzerland 31

Role of member states: compliance monitoring Dir. 2004/10/EC, Art. 3.1: "Member States shall adopt the measures necessary for verification of compliance with the principles of good laboratory practice. These measures shall include, in particular, inspections and study checks in accordance with the recommendations of the OECD in this area." Dir. 2004/9/EC, Art. 3: "Member States shall designate the authorities responsible for the inspection of laboratories within their territories" Compliance monitoring programmes are assessed by other countries through OECD / EU on-site evaluations 12

Role of member states: compliance monitoring ECJ Case C-95/08, Commission vs. Luxembourg: "The Court declares that by not putting in place the authorities able to verify the implementation of the principles of good laboratory practice, the Grand Duchy of Luxembourg has failed to fulfil its obligations under Article 3 of Directive 2004/9/EC" 13

Role of member states: authorities National monitoring authorities set up GLP compliance monitoring programmes, inspect laboratories on a regular basis and conduct audits on studies carried out by laboratories in order to assess compliance with GLP. Receiving authorities receive GLP data (non-clinical safety data); they may verify the GLP compliance status of a test facility or request a study audit by a monitoring authority European authorities: ECHA, EFSA, EMA National authorities, e.g. clinical trial authorities 14

Role of member states: internal market Dir. 2004/10/EC, Art. 5: "Member States may not, on grounds relating to the principles of GLP, prohibit, restrict or impede the placing on the market of chemical products if the principles applied by the laboratories concerned are in conformity" Dir. 2004/9/EC, Art. 5: "The results of laboratory inspections and study audits on GLP compliance carried out by a Member State shall be binding on the other Member States." 15

Role of member states: information exchange Dir. 2004/9/EC, Art. 4: "Each year, Member States shall draw up a report relating to the implementation of GLP within their territory. [ ] The reports shall be forwarded to the Commission each year, not later than 31 March." Dir. 2004/9/EC, Art. 6: "Where a Member State has sufficient reason to believe that a laboratory in another Member State claiming GLP compliance has not carried out a test in accordance with GLP, it may request further information from that Member State and in particular may request a study audit, possibly in conjunction with a new inspection." Annual EU GLP working group meetings in Brussels 16

Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role of the European Commission

Role of the European Commission Ensure uniform application of the GLP principles and compliance monitoring in all MS Facilitate acceptance of data among MS & by OECD MAD countries Regular meetings of MS experts in the EU GLP Working Group Coordination of information exchange on inspected laboratories Interaction between monitoring and EU receiving authorities Coordination of evaluation visits Participation in OECD working group meetings and coordination of EU MS views (all EU MS are OECD Members except BG/HR/CY/LT/LV/MT/RO) 18

Questions? More information (including full legal basis, list of national authorities and Q&A document): http://ec.europa.eu/enterprise/sectors/chemicals/documents/specifi c-chemicals/laboratory-practice/index_en.htm 19